ARTICLE - JULY 7, 2025 - ABOUTPHARMA
Confindustria Dispositivi Medici selects Rilemo for its Primary Site programme
Rilemo is one of ten startups chosen for the second edition of Primary Site, which offers regulatory training and support towards CE marking.
Read the full article on AboutPharmaConfindustria Dispositivi Medici, the Italian medical device industry association, selected ten startups for the second edition of Primary Site, its programme of regulatory training and support towards CE marking. Rilemo is one of them.
AboutPharma describes Rilemo as bringing to market a portable medical device based on electromagnetic imaging that diagnoses fluid-related conditions (stroke, oedema, haemorrhage) quickly and non-invasively, in both the acute and the chronic phase, and that takes diagnostics to the ward, the ambulance, the emergency room and the home.